InsidersTradesSigma
Discover the complete record of transactions filed by Corin Denis, 首席执行官. Director active across 1 company, notably Q BioMed Inc.. Aggregated, 1 filings have been recorded. History available since 26 May 2022. The latest transaction was filed on 26 May 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Denis Corin is the Chief Executive Officer of Q BioMed Inc. He is responsible for the strategic and operational direction of the company, focusing on innovation in the biopharmaceutical sector. His experience enables him to lead initiatives aimed at developing new treatments and improving healthcare quality.